On the contrary, IGF2BP1 upregulation in MNA neuroblastoma is supported by previous studies in primary tumors, MYC/MYCN-driven transcriptional regulation and conserved oncofetal expression of the protein (13, 14, 46, 47). The gene discussed is MYCN; the disease is neuroblastoma.